|
|
|
| L |
ST |
Personal information |
Details at diagnosis |
Initial treatment |
Second treatment |
Third treatment |
| |
|
Name |
Age |
Ctry |
Stars |
Date |
Age |
PSA |
GS |
T-Stad. |
Date |
PSA |
Treatment |
Date |
PSA |
Treatment |
Date |
PSA |
Treatment |
  |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
U |
SteveT |
76 |
 |
 |
21.06.07 |
61 |
19.6 |
3+3 |
T1c |
23.07.07 |
19.2 |
interm. ADT |
23.07.08 |
12.0 |
o. alt. med |
23.04.10 |
9.7 |
o. treatment |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
U |
Andreas 47 |
54 |
 |
|
24.07.14 |
47 |
6.2 |
3+4 |
T2c |
02.02.15 |
5.9 |
Active Surv. |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
michaelshn |
71 |
 |
|
11.05.06 |
55 |
3.3 |
4+5 |
|
11.05.06 |
3.3 |
Open surgery |
21.04.10 |
0.1 |
IMRT |
06.10.11 |
0.0 |
ADT2 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Roger Carnell |
79 |
 |
|
16.10.09 |
67 |
4.6 |
3+3 |
T1C |
16.10.09 |
4.6 |
Active Surv. |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Claus Lohmar |
58 |
 |
|
01.07.16 |
52 |
5.2 |
3+4 |
|
01.03.16 |
8.2 |
Active Surv. |
24.09.20 |
3.3 |
IMRT+ADT |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Marbuse-1951 |
71 |
 |
|
09.04.18 |
67 |
55.2 |
5+5 |
|
10.09.18 |
1.2 |
IMRT+ADT |
17.10.18 |
1.2 |
Protons+ADT |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
JohnA(eh?) |
74 |
 |
|
03.04.11 |
64 |
7.0 |
+ |
|
18.09.11 |
5.1 |
IMRT |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
KarlEmagne |
56 |
|
|
01.04.19 |
54 |
13.3 |
4+3 |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Wayne |
75 |
|
|
20.08.07 |
60 |
4.0 |
3+4 |
|
11.10.07 |
4.0 |
DaVinci |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
LesB1947 |
75 |
|
|
19.08.08 |
61 |
12.0 |
3+4 |
2 |
19.08.08 |
10.0 |
Watchful Wait. |
20.02.09 |
12.0 |
ADT1 |
19.11.09 |
0.0 |
Open surgery |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
PIMarine |
68 |
|
|
08.08.17 |
64 |
6.6 |
4+3 |
T1c |
01.10.18 |
7.1 |
Open surgery |
01.07.20 |
0.2 |
Protons |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Phil |
59 |
|
|
02.01.17 |
55 |
4.0 |
3+3 |
|
03.01.17 |
4.0 |
Active Surv. |
18.06.18 |
3.9 |
o. treatment |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Luis1945 |
77 |
 |
|
13.12.07 |
62 |
5.0 |
3+3 |
T1c |
04.02.08 |
5.0 |
Laparoscopy |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Toby_1962 |
60 |
 |
|
27.06.14 |
52 |
12.6 |
3+4 |
T2 |
18.07.14 |
12.6 |
DaVinci |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
JPW1944 |
78 |
|
|
03.07.08 |
64 |
5.8 |
3+3 |
T1c |
10.12.08 |
5.2 |
HDR-Brachy |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Dan Kasper |
67 |
|
|
11.04.12 |
57 |
71.4 |
4+3 |
|
06.11.12 |
71.4 |
ADT1 |
01.08.14 |
0.1 |
other ADT |
18.03.16 |
0.1 |
interm. ADT |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
Don_R |
65 |
|
|
15.02.13 |
57 |
101 |
4+5 |
T4 |
15.02.13 |
101 |
ADT1 |
04.03.13 |
98.7 |
ADT2 |
20.11.13 |
35.0 |
ADT1 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
F |
richard |
58 |
 |
|
06.12.11 |
47 |
6.0 |
3+3 |
pT2c |
14.12.11 |
6.0 |
Open surgery |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
|
EricW |
61 |
|
|
28.07.09 |
49 |
4.0 |
3+3 |
|
08.09.09 |
4.0 |
Open surgery |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
|
Pierrot.en |
75 |
 |
|
27.07.09 |
63 |
5.5 |
+ |
|
24.07.09 |
5.5 |
Watchful Wait. |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L |
ST |
Personal information |
Details at diagnosis |
Initial treatment |
Second treatment |
Third treatment |
| |
|
Name |
Age |
Ctry |
Stars |
Date |
Age |
PSA |
GS |
T-Stad. |
Date |
PSA |
Treatment |
Date |
PSA |
Treatment |
Date |
PSA |
Treatment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EN |
|
GM |
71 |
|
|
19.12.03 |
52 |
80.3 |
4+4 |
T3/4 |
12.01.04 |
86.8 |
ADT2 |
03.03.04 |
1.1 |
open surg.+ADT |
14.05.04 |
0.1 |
ADT3 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|